[
  {
    "ts": "2025-05-20T17:37:00+00:00",
    "headline": "Stryker (NYSE:SYK) Expands Pain Therapy With FDA Clearance For OptaBlate BVN System",
    "summary": "Stryker (NYSE:SYK) recently secured FDA clearance for its OptaBlate BVN system, aiming to enhance its portfolio in advanced pain therapy solutions. The company's share price rose 14% over the past month. This increase parallels the broader market trends, bolstered by their expansion efforts, such as pursuing mergers and acquisitions and the positive earnings guidance update. Additionally, the declaration of a 5% dividend increase likely provided investor confidence. While the market...",
    "url": "https://finance.yahoo.com/news/stryker-nyse-syk-expands-pain-173700642.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7bdb25ae-50bf-3164-9f7e-1a618cedcaa2",
      "content": {
        "id": "7bdb25ae-50bf-3164-9f7e-1a618cedcaa2",
        "contentType": "STORY",
        "title": "Stryker (NYSE:SYK) Expands Pain Therapy With FDA Clearance For OptaBlate BVN System",
        "description": "",
        "summary": "Stryker (NYSE:SYK) recently secured FDA clearance for its OptaBlate BVN system, aiming to enhance its portfolio in advanced pain therapy solutions. The company's share price rose 14% over the past month. This increase parallels the broader market trends, bolstered by their expansion efforts, such as pursuing mergers and acquisitions and the positive earnings guidance update. Additionally, the declaration of a 5% dividend increase likely provided investor confidence. While the market...",
        "pubDate": "2025-05-20T17:37:00Z",
        "displayTime": "2025-05-20T17:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vLi2clQ39cq4H4GDgg1AAA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hLmZY7hCIZ66l74wpB8KIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stryker-nyse-syk-expands-pain-173700642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stryker-nyse-syk-expands-pain-173700642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-05-20T13:22:00+00:00",
    "headline": "SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System",
    "summary": "Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.",
    "url": "https://finance.yahoo.com/news/syk-stock-likely-rise-following-132200418.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e6a11f66-ea5a-3ff9-9d7d-269556ae82e9",
      "content": {
        "id": "e6a11f66-ea5a-3ff9-9d7d-269556ae82e9",
        "contentType": "STORY",
        "title": "SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System",
        "description": "",
        "summary": "Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.",
        "pubDate": "2025-05-20T13:22:00Z",
        "displayTime": "2025-05-20T13:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rR6iZHXu8FRY2qc4ebuBNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TXlDKOevAW4cJAnlMECSwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/syk-stock-likely-rise-following-132200418.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/syk-stock-likely-rise-following-132200418.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SYK"
            },
            {
              "symbol": "ITGR"
            },
            {
              "symbol": "ANGO"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-05-20T03:33:19+00:00",
    "headline": "Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks",
    "summary": "As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.",
    "url": "https://finance.yahoo.com/news/unpacking-q1-earnings-baxter-nyse-033319124.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "691d0a73-0b5e-354d-8e47-a5eb66eba82f",
      "content": {
        "id": "691d0a73-0b5e-354d-8e47-a5eb66eba82f",
        "contentType": "STORY",
        "title": "Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks",
        "description": "",
        "summary": "As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.",
        "pubDate": "2025-05-20T03:33:19Z",
        "displayTime": "2025-05-20T03:33:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/6a692ea383b27aeed7a471f549f8a24d",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "BAX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cCa4vjLE0k5.Dn4UUOypjA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/6a692ea383b27aeed7a471f549f8a24d.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w3qN2NhZd5wAirUlnSNtVQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/6a692ea383b27aeed7a471f549f8a24d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/unpacking-q1-earnings-baxter-nyse-033319124.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/unpacking-q1-earnings-baxter-nyse-033319124.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAX"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "NEOG"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]